Fractyl Health, Inc. (NASDAQ:GUTS) Stock Short Interest Jumps 120.4%

Fractyl Health, Inc. (NASDAQ:GUTS – Get Free Report) saw a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 585,071 shares, a growth of 120.4% from the October 15th total of 265,423 shares. Approximately 4.8% of the shares of the company are short sold. Based on an average daily volume of 1,925,065 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

GUTS has been the subject of a number of recent research reports. Craig Hallum set a $5.00 price objective on Fractyl Health in a research note on Monday, October 19th. Morgan Stanley reduced their price target on shares of Fractyl Health to $4.00 and set an “equal weight” rating for the company in a report on Monday, October 19th. Weiss Ratings lowered shares of Fractyl Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, September 3rd. Finally, Wall Street Zen lowered shares of Fractyl Health from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $50.25.

Get Our Latest Stock Report on Fractyl Health

Hedge Funds Weigh In On Fractyl Health

Several hedge funds have recently modified their holdings of the company. Sanctuary Advisors LLC acquired a new position in Fractyl Health during the second quarter worth about $26,000. Private Advisor Group LLC bought a new position in shares of Fractyl Health during the 3rd quarter valued at about $27,000. FNY Investment Advisers LLC grew its stake in shares of Fractyl Health by 84.3% in the 2nd quarter. FNY Investment Advisers LLC now owns 65,420 shares of the company’s stock worth $51,000 after purchasing an additional 29,920 shares during the last quarter. PEAK6 LLC bought a new stake in shares of Fractyl Health in the 2nd quarter worth approximately $159,000. Finally, Mink Brook Asset Management LLC raised its holdings in shares of Fractyl Health by 62.5% in the 3rd quarter. Mink Brook Asset Management LLC now owns 573,145 shares of the company’s stock worth $312,000 after purchasing an additional 220,400 shares in the last quarter.

Fractyl Health Stock Performance

Shares of NASDAQ:GUTS traded up $0.14 on Monday, hitting $1.04. The company’s stock had a trading volume of 454,500 shares, compared to its average volume of 338,519. Fractyl Health has a 12 month low of $0.80 and a 12 month high of $29.34. The company has a market capitalization of $13.84 million, a price-to-earnings ratio of -0.34 and a beta of 2.91. The stock’s 50-day moving average is $3.89 and its two-hundred day moving average is $6.87. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.98 and a current ratio of 1.98.

Fractyl Health (NASDAQ:GUTS – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($1.07) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.43. On average, equities research analysts forecast that Fractyl Health will post -5.88 EPS for the current year.

Fractyl Health Company Profile

(Get Free Report)

Fractyl Health is a clinical-stage therapeutics company focused on developing treatments for metabolic diseases, including type 2 diabetes and obesity. The company is based in Burlington, Massachusetts. Its lead program, Revita, is an investigational endoscopic procedure designed to resurface the lining of the duodenum, the first part of the small intestine. Fractyl is studying whether this approach can improve metabolic function and provide lasting benefits for people with type 2 diabetes. The company is also developing Rejuva, an experimental gene therapy platform intended to address obesity and related metabolic conditions.

Further Reading

Receive News & Ratings for Fractyl Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fractyl Health and related companies with MarketBeat.com's FREE daily email newsletter.